| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/28/2006 | WO2006100108A1 Fermentation process for the production of diphtheria toxin |
| 09/28/2006 | WO2006099961A1 Device and method for cell free analytical and preparative protein synthesis |
| 09/28/2006 | WO2006051545A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/28/2006 | WO2006014899A3 Process for improved protein expression by strain engineering |
| 09/28/2006 | WO2005104835A3 Transgenic animals and uses thereof |
| 09/28/2006 | WO2005074650A3 Modified human four helical bundle polypeptides and their uses |
| 09/28/2006 | WO2004089305A3 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same |
| 09/28/2006 | WO2004046330A3 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 09/28/2006 | WO2003076578A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/28/2006 | WO2003057857A3 Antibodies directed to pdgfd and uses thereof |
| 09/28/2006 | WO2002083872A3 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites |
| 09/28/2006 | US20060218671 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 09/28/2006 | US20060218655 Used for identifying a drug capable of treating a B cell lymphoma, capable of depleting or killing cells expressing human CD20, or capable of inducing an Fc-mediated effector cell response; testing the safety or efficacy of anti-human CD20 therapy |
| 09/28/2006 | US20060218653 determining that a single nucleotide point mutation in the fourth exon of the nucleic acid sequence encoding dog CLN5 results in the production of a variant soluble lysosomal glycoprotein, specifically CLN5, which exhibits aberrant functional activity |
| 09/28/2006 | US20060217536 Monoclonal antibody that has an extremely high binding ability to human ZAQL-1 and can neutralize or inhibit its activity, useful for diagnosing, preventing and treating endometrial cancer, endometriosis or ovulation disorders. |
| 09/28/2006 | US20060217535 Hemipteran muscarinic receptor |
| 09/28/2006 | US20060217532 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217360 Tubulysin biosynthesis gene |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060217318 Ace inhibitory peptides from plant materials |
| 09/28/2006 | US20060217310 Fibroblast growth factor 1 (FGF-1) used for skin care |
| 09/28/2006 | US20060217298 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 09/28/2006 | US20060216809 cGMP-binding, cGMP-specific phosphodiesterase materials and methods |
| 09/28/2006 | US20060216808 Isolated, recombinantly produced, enzymatically active hyaluronan synthase; a single protein that is a dual-action catalyst that utilizes UDP-GlcA and UDP-GlcNAc to synthesize hyaluronic acid |
| 09/28/2006 | US20060216794 Hyaluronan synthase gene and uses thereof |
| 09/28/2006 | US20060216793 Culturing Bacillus strain with purified nucleic acid segment having coding region encoding enzymatically active hyaluronan synthase to produce hyaluronic acid; genetic engineering |
| 09/28/2006 | US20060216791 Method for synthesizing amino-acid-selectively labeled protein |
| 09/28/2006 | US20060216790 monitoring concentration of dissolved CO2 in the culture liquid, constantly or intermittently sparging atmospheric air through culture liquid, while sparging rate of the air is controlled in relation to the monitored concentration of dissolved CO2, to produce blood coagulation factor VII polypeptide |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216787 Modified Shine-Dalgarno sequences and methods of uses thereof |
| 09/28/2006 | US20060216786 Feline interferon-alpha proteins |
| 09/28/2006 | US20060216785 Genetic engineering; fusion protein; comprising a recombinant vector containing a nucleic acid sequence encoding a ubiquitin like molecule (UBL) molecule selected from the group of SUMO, RUB, HUB, URM1, and ISG15 operably linked to a promoter suitable for expression in the desired host cell |
| 09/28/2006 | US20060216784 Process for production of polypeptides |
| 09/28/2006 | US20060216783 Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host |
| 09/28/2006 | US20060216782 Methods for expression and purification of immunotoxins |
| 09/28/2006 | US20060216776 Screening assay for agents that alter target of rapamycin activity |
| 09/28/2006 | US20060216770 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216750 New lipid binding protein 1 |
| 09/28/2006 | US20060216749 Chimeric gaba receptor |
| 09/28/2006 | US20060216748 Genes differentially expressed in breast cancer |
| 09/28/2006 | US20060216746 Novel protein and DNA thereof |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216730 Novel human protein kinases and protein kinase-like enzymes |
| 09/28/2006 | US20060216727 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/28/2006 | US20060216719 Novel short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use |
| 09/28/2006 | US20060216711 Variants of cytochrome c and methods of diagnosis of thrombocytopenia |
| 09/28/2006 | US20060216710 Screening for compound that activates or inhibits activity of Aster Associated Protein; over-expression disrupts mitotic spindle assembly and leads to aberrant and abortive mitosis |
| 09/28/2006 | US20060216709 Midkine-like protein |
| 09/28/2006 | US20060216706 Proteins associated with cell growth, differentiation, and death |
| 09/28/2006 | US20060216703 Extraction and concentration method |
| 09/28/2006 | US20060216699 Peptides for the detection of HIV-1 group O |
| 09/28/2006 | US20060216698 Fusion expression vector containing the His-tagged Vitreoscilla hemoglobin coding gene |
| 09/28/2006 | US20060216330 Peptides having an ace inhibiting effect |
| 09/28/2006 | US20060216307 Vaccine composition |
| 09/28/2006 | US20060216304 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216291 Glycoprotein VI and uses thereof |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216281 Process for producing aglycon and flavor-improved food containing the aglycon by diglycosidase, and converting agent to be used in the process |
| 09/28/2006 | US20060216279 Myostatin inhibiting fusion polypeptides and therapeutic methods thereof |
| 09/28/2006 | US20060216270 DNA 19355 polypeptide, a tumor necrosis factor homolog |
| 09/28/2006 | US20060216231 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 09/28/2006 | CA2611859A1 Cellulases, nucleic acids encoding them and methods for making and using them |
| 09/28/2006 | CA2602329A1 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms |
| 09/28/2006 | CA2602143A1 Fermentation process for the production of diphtheria toxin |
| 09/28/2006 | CA2602035A1 Framework-shuffling of antibodies |
| 09/28/2006 | CA2601574A1 Methods and compositions for producing active vitamin k-dependent proteins |
| 09/28/2006 | CA2600693A1 Process for microbial production of a valuable compound |
| 09/27/2006 | EP1705255A2 Diagnostic method and kit for determining Kell blood group genotype |
| 09/27/2006 | EP1705251A1 PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY USING RNA INHIBITING THE FUNCTION OF a1,6-FUCOSYLTRANSFERASE |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705185A2 Reagent for the diagnosis of rheumatoid arthritis |
| 09/27/2006 | EP1704242A2 COMPOSITIONS OF ORTHOGONAL LEUCYL-tRNA AND AMINOACYL-tRNA SYNTHETASE PAIRS AND USES THEREOF |
| 09/27/2006 | EP1704234A2 Production of glucagon like peptide 2 and analogs |
| 09/27/2006 | EP1704227A1 Immortalized hepatocytes |
| 09/27/2006 | EP1307560B1 Schizophrenia related gene and protein |
| 09/27/2006 | EP1303537B1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/27/2006 | EP1012303B1 Factor x deletion mutants and analogues thereof |
| 09/27/2006 | EP0770628B1 Reconstituted human antibody against human interleukin-8 |
| 09/27/2006 | CN1839206A RNA interferases and methods of use thereof |
| 09/27/2006 | CN1839148A Cytotoxic depsipeptides |
| 09/27/2006 | CN1837237A Recombinant human interleukin1 receptor antagon (rhIL-1ra) with low pyrogen and its high efficiency preparation process |
| 09/27/2006 | CN1836669A Method for preparing sheep placenta extract |
| 09/27/2006 | CN1276975C Recombinant protein containing C-terminal fragment of plasmodium MSP-1 |
| 09/26/2006 | US7112667 Sequences of an Ih ion channel and use thereof |
| 09/26/2006 | US7112664 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis; A transformant E. coli DH5 alpha /YRC-pCRA9Hv; |
| 09/26/2006 | US7112662 Anti-metasin antibodies and their methods of use |
| 09/26/2006 | US7112661 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha |
| 09/26/2006 | US7112660 Modified cytokine |
| 09/26/2006 | US7112564 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 09/26/2006 | US7112562 Insulin conjugates and methods of use thereof |
| 09/26/2006 | US7112430 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 09/26/2006 | US7112429 Bulking agent for foods; genetic engineering; analyzing, calibration carbohydrate degradation using mannanases |
| 09/26/2006 | US7112428 hydroxycarboxylic ester asymmetric hydrolase (EnHCH); genetic engineering; optical actvity; for medicines, agricultural chemicals, and strongly dielectic liquid crystal |
| 09/26/2006 | US7112427 Protein comprising mitogenic kinase activity for identifying modulators of inflammation, apoptosis and cell proliferation; antiproliferative agents |
| 09/26/2006 | US7112426 Human cAMP-dependent protein kinase beta-catalytic subunit |
| 09/26/2006 | US7112425 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives |